EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Type 2 airway inflammation in COPD

Francesca Polverino, Don D Sin

European Respiratory Journal · 2024-05 · 63 (5) · 2400150

DOI: 10.1183/13993003.00150-2024 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Respiratory Journal, online erschienen am 14.03.2024. Verfasst von Francesca Polverino und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary and Critical Care Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX, USA. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Inflammation. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 92 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Globally, nearly 400 million persons have COPD, and COPD is one of the leading causes of hospitalisation and mortality across the world. While it has been long-recognised that COPD is an inflammatory lung disease, dissimilar to asthma, type 2 inflammation was thought to play a minor role. However, recent studies suggest that in approximately one third of patients with COPD, type 2 inflammation may be an important driver of disease and a potential therapeutic target. Importantly, the immune cells and molecules involved in COPD-related type 2 immunity may be significantly different from those observed in severe asthma. Here, we identify the important molecules and effector immune cells involved in type 2 airway inflammation in COPD, discuss the recent therapeutic trial results of biologicals that have targeted these pathways and explore the future of therapeutic development of type 2 immune modulators in COPD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveInflammationHumansTh2 CellsAsthma

Autor:innen und Institutionen

  • Pulmonary and Critical Care Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Centre for Heart Lung Innovation, St. Paul's Hospital and University of British Columbia Division of Respiratory Medicine, Vancouver, BC, Canada Don.Sin@hli.ubc.ca.

Zitieren

APA

Polverino, F., & Sin, D. D. (2024). Type 2 airway inflammation in COPD. European Respiratory Journal, 63(5), 2400150. https://doi.org/10.1183/13993003.00150-2024

Vancouver

Polverino F, Sin DD. Type 2 airway inflammation in COPD. European Respiratory Journal. 2024;63(5):2400150. doi:10.1183/13993003.00150-2024

BibTeX
@article{Polverino2024,
  author = {Polverino, Francesca and Sin, Don D},
  title = {Type 2 airway inflammation in COPD},
  journal = {European Respiratory Journal},
  year = {2024},
  volume = {63},
  number = {5},
  pages = {2400150},
  doi = {10.1183/13993003.00150-2024}
}
Kostenlos starten →